drugset / Trial / NCT06459310

Pilot Study on Evaluating the Geroprotective Effect of Metformin

NCT06459310 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.

Timeline

Start
2024-06-30
Primary completion
2026-09-30
Completion
2028-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg Oral